DAFNA Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03M | Buy |
371,523
+62,323
| +20% | +$843K | 1.39% | 21 |
|
|
2025
Q1 | $4.91M | Buy |
309,200
+162,700
| +111% | +$2.58M | 1.39% | 20 |
|
|
2024
Q4 | $1.8M | Hold |
146,500
| – | – | 0.46% | 42 |
|
|
2024
Q3 | $1.77M | Buy |
146,500
+27,500
| +23% | +$333K | 0.42% | 48 |
|
|
2024
Q2 | $1.39M | Buy |
119,000
+29,000
| +32% | +$339K | 0.33% | 52 |
|
|
2024
Q1 | $1.16M | Buy |
90,000
+74,800
| +492% | +$966K | 0.26% | 58 |
|
|
2023
Q4 | $131K | Buy |
+15,200
| New | +$131K | 0.03% | 74 |
|